Role of Human Papillomavirus in Penile Carcinomas WorldwideReportar como inadecuado

Role of Human Papillomavirus in Penile Carcinomas Worldwide - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.


Background: Invasive penile cancer is a rare disease with an approximately 22 000 cases per year. The incidence is higher in less developed countries, where penile cancer can account for up to 10% of cancers among men in some parts of Africa, South America, and Asia. Objective: To describe the human papillomavirus HPV DNA prevalence, HPV type distribution, and detection of markers of viral activity ie, E6*I mRNA and p16INK4a in a series of invasive penile cancers and penile high-grade squamous intraepithelial lesions HGSILs from 25 countries. A total of 85 penile HGSILs and 1010 penile invasive cancers diagnosed from 1983 to 2011 were included. Design, setting, and participants: After histopathologic evaluation of formalin-fixed paraffin-embedded samples, HPV DNA detection and genotyping were performed using the SPF-10-DEIA-LiPA25 system, v.1 Laboratory Biomedical Products, Rijswijk, The Netherlands. HPV DNA-positive cases were additionally tested for oncogene E6*I mRNA and all cases for p16INK4a expression, a surrogate marker of oncogenic HPV activity. Outcome measurements and statistical analysis: HPV DNA prevalence and type distributions were estimated. Results and limitations: HPV DNA was detected in 33.1% of penile cancers 95% confidence interval CI, 30.2-36.1 and in 87.1% of HGSILs 95% CI, 78.0-93.4. The warty-basaloid histologic subtype showed the highest HPV DNA prevalence. Among cancers, statistically significant differences in prevalence were observed only by geographic region and not by period or by age at diagnosis. HPV16 was the most frequent HPV type detected in both HPV-positive cancers 68.7% and HGSILs 79.6%. HPV6 was the second most common type in invasive cancers 3.7%. The p16INK4a upregulation and mRNA detection in addition to HPV DNA positivity were observed in 69.3% of HGSILs, and at least one of these HPV activity markers was detected in 85.3% of cases. In penile cancers, these figures were 22.0% and 27.1%, respectively. Conclusions: About a third to a fourth of penile cancers were related to HPV when considering HPV DNA detection alone or adding an HPV activity marker, respectively. The observed HPV type distribution reinforces the potential benefit of current and new HPV vaccines in the reduction of HPV-related penile neoplastic lesions. Patient summary: About one-third to one-quarter of penile cancers were related to human papillomavirus HPV. The observed HPV type distribution reinforces the potential benefit of current and new HPV vaccines to prevent HPV-related penile neoplastic lesions.Nota general

Artículo de publicación ISI

Autor: Alemany, Laia; - Cubilla, Antonio; - Halec, Gordana; - Kasamatsu, Elena; - Quiros, Beatriz; - Masferrer, Emili; - Tous, Sara; - L



Documentos relacionados